Latest Ratios: P/E Ratio 52.8x · EV/EBITDA 14.1x · ROE 1.6%. (1998–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.3B | $969M | $1.8B | $1.9B | $2.0B | $2.0B | $1.5B | $1.8B | $2.5B | $4.2B | $4.7B |
| Enterprise Value | $2.6B | $2.3B | $3.0B | $3.1B | $3.3B | $2.8B | $2.5B | $2.6B | $3.6B | $5.2B | $5.9B |
| P/E Ratio → | 52.75 | 38.42 | 18.45 | 16.72 | 20.11 | 17.12 | 22.48 | — | 24.33 | 727.70 | 26.60 |
| P/S Ratio | 0.58 | 0.44 | 0.81 | 0.85 | 0.92 | 0.96 | 0.78 | 0.82 | 1.13 | 1.82 | 2.01 |
| P/B Ratio | 0.86 | 0.62 | 1.15 | 1.24 | 1.37 | 1.26 | 1.06 | 1.33 | 1.44 | 2.40 | 2.60 |
| P/FCF | 31.12 | 23.41 | 10.43 | 11.49 | 43.96 | 11.64 | 8.23 | 13.26 | 12.43 | 18.42 | 44.41 |
| P/OCF | 10.88 | 8.19 | 7.88 | 8.86 | 19.65 | 8.75 | 6.54 | 9.22 | 9.52 | 14.13 | 26.91 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.03 | 1.33 | 1.40 | 1.51 | 1.36 | 1.26 | 1.24 | 1.59 | 2.27 | 2.48 |
| EV / EBITDA | 14.05 | 12.33 | 10.43 | 9.88 | 12.04 | 8.69 | 9.29 | 7.84 | 9.32 | 11.83 | 13.57 |
| EV / EBIT | 26.97 | 23.61 | 15.19 | 13.91 | 16.76 | 13.22 | 16.57 | — | 15.32 | 320.62 | 20.06 |
| EV / FCF | — | 55.21 | 17.18 | 18.88 | 71.86 | 16.51 | 13.31 | 19.95 | 17.51 | 23.00 | 54.75 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 41.6% | 41.6% | 42.4% | 41.8% | 40.5% | 45.6% | 45.2% | 45.1% | 46.2% | 49.0% | 49.1% |
| Operating Margin | 4.3% | 4.3% | 8.8% | 10.1% | 8.4% | 11.5% | 9.0% | 11.4% | 12.7% | 15.1% | 14.3% |
| Net Profit Margin | 1.1% | 1.1% | 4.4% | 5.1% | 4.6% | 5.6% | 3.5% | -17.4% | 4.6% | 0.2% | 7.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.6% | 1.6% | 6.3% | 7.6% | 6.5% | 7.8% | 4.9% | -24.3% | 5.9% | 0.3% | 9.7% |
| ROA | 0.7% | 0.7% | 2.6% | 3.1% | 2.7% | 3.3% | 1.9% | -10.1% | 2.5% | 0.1% | 3.7% |
| ROIC | 2.6% | 2.6% | 5.4% | 6.2% | 5.3% | 7.5% | 5.8% | 7.3% | 7.6% | 9.1% | 8.7% |
| ROCE | 3.0% | 3.0% | 6.2% | 7.1% | 5.8% | 7.8% | 6.1% | 8.1% | 8.2% | 9.2% | 8.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.99 | 0.99 | 0.87 | 0.94 | 1.00 | 0.83 | 0.91 | 0.93 | 0.74 | 0.89 | 1.01 |
| Debt / EBITDA | 8.32 | 8.32 | 4.82 | 4.55 | 5.37 | 4.03 | 4.92 | 3.64 | 3.40 | 3.50 | 4.28 |
| Net Debt / Equity | — | 0.85 | 0.74 | 0.80 | 0.87 | 0.53 | 0.65 | 0.67 | 0.59 | 0.60 | 0.60 |
| Net Debt / EBITDA | 7.10 | 7.10 | 4.10 | 3.87 | 4.67 | 2.57 | 3.54 | 2.63 | 2.70 | 2.36 | 2.56 |
| Debt / FCF | — | 31.80 | 6.74 | 7.39 | 27.89 | 4.87 | 5.07 | 6.69 | 5.08 | 4.59 | 10.34 |
| Interest Coverage | 1.32 | 1.32 | 2.58 | 2.88 | 2.74 | 3.17 | 2.43 | -5.23 | 3.41 | 0.24 | 4.06 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.76 | 1.76 | 1.66 | 1.84 | 1.75 | 2.12 | 1.93 | 1.58 | 1.33 | 2.26 | 1.67 |
| Quick Ratio | 0.90 | 0.90 | 0.81 | 0.90 | 0.91 | 1.47 | 1.31 | 1.04 | 0.87 | 1.63 | 1.32 |
| Cash Ratio | 0.40 | 0.40 | 0.37 | 0.41 | 0.35 | 0.89 | 0.71 | 0.52 | 0.37 | 0.96 | 0.85 |
| Asset Turnover | — | 0.59 | 0.60 | 0.60 | 0.58 | 0.57 | 0.55 | 0.62 | 0.57 | 0.55 | 0.50 |
| Inventory Turnover | 2.68 | 2.68 | 2.72 | 2.66 | 2.87 | 3.29 | 3.40 | 3.29 | 3.65 | 3.52 | 3.89 |
| Days Sales Outstanding | — | 31.98 | 26.58 | 27.36 | 35.11 | 40.32 | 43.02 | 35.05 | 39.06 | 38.27 | 44.78 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.2% | 3.0% | 1.7% | 1.6% | 1.6% | 1.3% | — | — | — | — | — |
| Payout Ratio | 115.4% | 115.4% | 31.1% | 27.5% | 32.8% | 21.7% | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.9% | 2.6% | 5.4% | 6.0% | 5.0% | 5.8% | 4.4% | — | 4.1% | 0.1% | 3.8% |
| FCF Yield | 3.2% | 4.3% | 9.6% | 8.7% | 2.3% | 8.6% | 12.1% | 7.5% | 8.0% | 5.4% | 2.3% |
| Buyback Yield | 7.0% | 9.3% | 3.2% | 3.9% | 6.3% | 0.5% | 0.0% | 0.2% | 4.9% | 4.0% | 4.1% |
| Total Shareholder Yield | 9.2% | 12.3% | 4.9% | 5.6% | 7.9% | 1.7% | 0.0% | 0.2% | 4.9% | 4.0% | 4.1% |
| Shares Outstanding | — | $48M | $50M | $52M | $54M | $55M | $55M | $54M | $55M | $58M | $60M |
Includes 30+ ratios · 28 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EPC stock.
Edgewell Personal Care Company's current P/E ratio is 52.8x. The historical average is 15.8x. This places it at the 100th percentile of its historical range.
Edgewell Personal Care Company's current EV/EBITDA is 14.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.6x.
Edgewell Personal Care Company's return on equity (ROE) is 1.6%. The historical average is 17.3%.
Based on historical data, Edgewell Personal Care Company is trading at a P/E of 52.8x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Edgewell Personal Care Company's current dividend yield is 2.20% with a payout ratio of 115.4%.
Edgewell Personal Care Company has 41.6% gross margin and 4.3% operating margin.
Edgewell Personal Care Company's Debt/EBITDA ratio is 8.3x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Thin margins and revenue decline
Metrics are mathematically derived from official filings.
Margin Compression Masks Underlying Stability
Gross margin averaged 41.6% but dipped to 38.1% in 2026Q1, while net margin swung to -15.5%, indicating severe quarterly volatility. According to the latest financial statements, operating margin has ranged from -6.8% to 12.8% over the past ten quarters.
The reported net margin of 1.14% TTM is heavily distorted by one-time charges and seasonal swings, as evidenced by the 2026Q1 net loss of $65.7M. Adjusted figures, as noted in the recent earnings release, suggest underlying profitability is better than GAAP numbers imply, but the persistent gap between reported and adjusted earnings warrants close monitoring. The gross margin decline from 44.3% in 2024Q3 to 42.5% in 2026Q3 indicates input cost pressures that the company has not fully offset through pricing.
Return on Capital Stuck in Low Single Digits
ROIC has averaged roughly 1% over the last ten quarters, with a peak of 2.3% in 2024Q3 and a trough of -1.0% in 2025Q4. Based on reported figures, ROE has similarly languished, reflecting a business that is not compounding returns on invested capital.
The consistently low ROIC, despite a stable asset base, suggests that Edgewell's capital allocation has not generated meaningful excess returns. The recent acquisition spree, including $338.9M deployed in 2026Q2-Q3, has yet to show up in improved returns, and the goodwill-heavy balance sheet (31% of assets) raises the risk of future impairments. Investors should monitor whether the integration of Cremo and Jack Black can lift ROIC above the cost of capital, which appears unlikely at current margin levels.
Working Capital Efficiency Deteriorates
Cash conversion cycle has lengthened from 96 days in 2024Q3 to 95 days in 2026Q3, but with significant interim volatility, peaking at 128 days in 2026Q1. As reported in the latest quarterly data, DIO has risen from 120 to 123 days, indicating slower inventory turnover.
The extended DIO, particularly in the Sun Care segment, suggests potential overstocking ahead of the summer season, which could lead to write-downs if demand disappoints. DSO has also crept up from 29 to 36 days over the same period, implying a slight loosening of credit terms or collection issues. The negative working capital swings, which drove operating cash flow to exceed net income by 8.66x in 2026Q3, highlight the seasonal nature of the business and the need to normalize for these fluctuations when assessing efficiency.
Leverage Creeps Higher with Coverage Thin
Debt-to-equity has risen from 0.83 in 2024Q3 to 0.88 in 2026Q3, while interest coverage has deteriorated from 4.32x to 0.92x over the same period. According to the latest balance sheet data, total debt stands at $1.3B against a thin equity base.
The sharp decline in interest coverage, driven by falling operating income and rising debt levels, suggests that debt service is becoming less comfortable. The D/EBITDA ratio spiked to 41.0x in 2026Q3, though this is distorted by depressed EBITDA; on a normalized basis, leverage appears manageable but warrants monitoring. The company's ability to refinance at favorable rates may be challenged if margins do not recover, given the current interest coverage below 1x in the most recent quarter.
Liquidity Buffer Strengthens but Relies on Inventory
Current ratio improved to 1.84 in 2026Q3 from 1.66 in 2024Q4, while quick ratio rose to 1.12, indicating a stronger liquidity position. As reported in the balance sheet, cash increased to $397.1M, providing a cushion against seasonal working capital needs.
The improvement in liquidity is partly driven by a build-up in inventory, which may not be readily convertible to cash in a downturn. The quick ratio of 1.12 suggests that even without selling inventory, the company can cover short-term obligations, but the reliance on seasonal inventory sales in the Sun Care segment introduces risk. Under a severe stress scenario, such as a prolonged cool summer, the company could face write-downs that erode this liquidity buffer.
P/E Misleads on Earnings Power
The trailing P/E of 53.72 is distorted by depressed earnings, while the forward P/E of 14.99 suggests the market expects a sharp recovery. Based on reported figures, EV/EBITDA of 14.18 is more reflective of the company's true valuation, but even that may overstate earnings quality.
The most commonly misapplied ratio for Edgewell is the P/E, because the company's earnings are heavily impacted by one-time charges, restructuring costs, and seasonal swings, making the trailing multiple meaningless. Investors should instead focus on EV/EBITDA or EV/EBIT, which normalize for capital structure and non-cash charges. However, even EV/EBITDA must be adjusted for the company's high goodwill and potential impairment risk, as well as the volatility in working capital that distorts cash flow. A more appropriate metric would be EV/EBITDAR or a normalized FCF yield, which better captures the underlying cash generation of the business.